Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Flubendazole: Strategic Autophagy Modulation in Cancer Model
2026-05-03
This thought-leadership article explores how Flubendazole (methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate) unlocks novel opportunities for translational researchers investigating autophagy signaling in cancer biology. Drawing on new mechanistic findings and workflow-oriented protocol advice, we illuminate strategic considerations for deploying this APExBIO compound in advanced breast cancer models and beyond.
-
Methyl-β-cyclodextrin: Technical Use in Membrane Cholesterol
2026-05-02
Methyl-β-cyclodextrin (SKU C6939) is employed for membrane cholesterol extraction, lipid raft disruption, and modulation of membrane fluidity in biochemical and cell-based research. It is intended exclusively for laboratory research and is not suitable for clinical or diagnostic procedures.
-
Carbon-Ion Radiotherapy Promotes Ferroptosis in Gastric Canc
2026-05-02
Wang and Cai (2025) reveal that carbon-ion radiotherapy (CIRT) suppresses gastric cancer progression by inducing ferroptosis and promoting M1 macrophage polarization via DHODH downregulation. These findings clarify the mechanistic advantages of CIRT and suggest DHODH as a promising therapeutic target, with implications for improving radiotherapy resistance in advanced gastric cancer.
-
QNZ (EVP4593): Precision NF-κB Inhibition for Neurodegenerat
2026-05-01
QNZ (EVP4593) stands apart as a nanomolar-potency NF-κB pathway inhibitor, purpose-built for dissecting inflammation and neurodegenerative mechanisms. This article delivers actionable workflow protocols, troubleshooting insights, and research-driven optimizations for maximizing QNZ’s translational value in disease modeling.
-
Micro- and Nanoplastics Heighten Pulmonary Fibrosis Risk in
2026-04-30
This study systematically compares the pulmonary toxicity of microplastics and nanoplastics (PS, PE, PP) in vivo and in vitro, revealing that particle size and polymer type critically modulate fibrogenic and inflammatory responses. Mechanistic insights implicate the FXR-YAP1 axis in mediating these effects, with polystyrene nanoplastics exhibiting the highest toxicity, informing both environmental risk assessments and molecular toxicology research.
-
HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Advanced Pro
2026-04-30
The HyperScribe T7 High Yield Cy5 RNA Labeling Kit streamlines fluorescent RNA probe synthesis for in situ and Northern blot hybridizations, delivering high labeling efficiency and reproducibility. Its optimized workflow and customizable Cy5-UTP incorporation empower researchers to tackle complex RNA–protein interaction studies, such as those revealing viral assembly mechanisms.
-
PreScission Protease: Enabling Next-Gen Condensate Biology
2026-04-29
Discover how PreScission Protease (PSP) advances biomolecular condensate research and protein purification. This in-depth analysis explores PSP's HRV 3C protease mechanism, unique cold-active properties, and practical assay guidance, highlighting innovations for molecular biology workflows.
-
BCL-XL Inhibitor A-1155463: Applied Workflows in Cancer Rese
2026-04-29
The selective BCL-XL inhibitor A-1155463 enables precise apoptosis induction in BCL-XL-dependent cancer models, outperforming earlier tools in both potency and selectivity. This guide unpacks optimized workflows, troubleshooting, and direct applications for overcoming drug resistance in solid tumors and hematological malignancies.
-
Roscovitine (Seliciclib): Strategic Leverage in Translationa
2026-04-28
This thought-leadership article explores the mechanistic underpinnings and translational impact of Roscovitine (Seliciclib, CYC202), highlighting its role as a benchmark selective CDK inhibitor for cell cycle arrest and tumor growth inhibition in vivo. We synthesize recent cheminformatics insights, protocol guidance, and competitive analysis to guide translational researchers in optimizing their experimental and preclinical strategies. Expanding on existing resources, this article offers a forward-looking perspective on library design, phenotypic screening, and the evolving translational landscape.
-
Tacalcitol Monohydrate: Next-Gen Precision in Cancer & Skin
2026-04-28
Explore how Tacalcitol monohydrate, a synthetic analog of vitamin D3, enables precise gene modulation for advanced cancer and dermatology research. Discover unique mechanistic insights and evidence-driven protocols that set this article apart.
-
Kanamycin Sulfate (SKU A2516): Reliable Solutions for Cell-B
2026-04-27
This article addresses real-world challenges in cell viability, proliferation, and antibiotic selection workflows, demonstrating how Kanamycin Sulfate (SKU A2516) supports reproducibility and data integrity. Scenario-driven Q&A blocks guide researchers through protocol optimization, product selection, and interpretation, anchored by evidence and best practices. APExBIO’s formulation is positioned as a robust, water-soluble antibiotic for advanced biomedical research.
-
Strategic NRF2 Inhibition: ML385 in Translational Oncology
2026-04-27
This thought-leadership article offers translational researchers a sophisticated mechanistic and strategic perspective on targeting NRF2 with ML385. It synthesizes recent findings in cancer and liver disease, integrates protocol guidance, and positions APExBIO’s ML385 as a linchpin for dissecting oxidative stress, ferroptosis, and therapeutic resistance. The piece differentiates itself by bridging evidence from oncology to liver research, contextualizing ML385’s unique value for innovative experimental design.
-
Zona Incerta SST Neurons Modulate Stress and Depression Circ
2026-04-26
This study identifies somatostatin-expressing neurons in the zona incerta (ZISST neurons) as key regulators of chronic stress response and depression-like behaviors in mice. The research elucidates circuit-level mechanisms underlying depression, highlighting potential new targets for therapeutic intervention.
-
Poria cocos Polysaccharides Mitigate ALD via NRF2-Regulated
2026-04-25
This study demonstrates that Poria cocos polysaccharides (PCP) ameliorate alcoholic liver disease (ALD) by regulating ferroptosis through NRF2 signaling. The findings clarify the mechanistic link between oxidative stress, ferroptosis, and NRF2 modulation in ALD, with translational implications for NRF2 inhibitor research.
-
MIZ1-TMBIM4 Axis Regulates IgG1+ Germinal Center B Cell Surv
2026-04-24
This study uncovers how the transcription factor MIZ1 and its downstream effector TMBIM4 uniquely sustain survival of IgG1+ germinal center B cells during positive selection. By dissecting isotype-specific dependencies in B cell fate, the work advances our understanding of affinity maturation and apoptosis regulation in humoral immunity.